empty
05.02.2025 12:44 AM
Pfizer Stock Rises: Why Now is the Best Time to Trade?

On Tuesday, shares of Pfizer Inc. rose by 1.7% in pre-market trading following the release of its Q4 2024 financial report, which exceeded analysts' expectations.

The American pharmaceutical giant reported a net profit of $410 million, or 7 cents per share. This represents a significant improvement compared to a loss of $3.37 billion, or 60 cents per share, during the same period last year.

The company's revenue increased by 22%, totaling $17.76 billion, compared to $14.57 billion in Q4 2023. This performance surpassed FactSet's consensus estimate of $17.35 billion.

This image is no longer relevant

This growth is primarily due to a one-time non-cash revenue return of $3.5 billion associated with its antiviral drug Paxlovid. Additionally, there has been an increase in sales from the Seagen oncology portfolio, the Vyndaqel family for cardiovascular treatment, and overall growth in Paxlovid sales.

Total sales of Paxlovid reached $727 million, a significant improvement compared to the $3.14 billion loss recorded last year, which stemmed from the transition to a traditional commercial sales model in the U.S.

Furthermore, Pfizer experienced a positive impact from currency fluctuations, which added an extra $62 million to its overall revenue. The company's management has reaffirmed its forecast for 2025, projecting revenue between $61 billion and $64 billion, with adjusted earnings per share ranging from $2.80 to $3.00.

According to FactSet, the average analyst expectations are for revenue of $63.07 billion and earnings of $2.91 per share.

Pfizer's CFO, David Denton, expressed confidence that the company will return to pre-pandemic operational margin levels in the coming years and achieve total cost savings of $4.5 billion by the end of 2025.

This situation presents several opportunities for traders. Pfizer's stock has risen following a strong earnings report, which may indicate a continuation of this upward trend, making the company's shares attractive for short- and medium-term speculative trades.

Furthermore, considering the company's long-term prospects in innovative drug development, Pfizer remains a promising asset for investors seeking stable capital growth.

Access to Pfizer shares and other leading global companies is available through the InstaForex trading platform.

Fast order execution, a wide range of instruments including CFDs on U.S. stocks, and no deposit restrictions enable traders to respond swiftly to market changes.

The availability of leverage up to 1:1000 and low commissions also provides additional opportunities for effective capital management.

Given the high volatility in the pharmaceutical sector and the upcoming release of key data on drug sales, investors should monitor Pfizer's stock closely.

In the upcoming quarters, the company is expected to continue growing its revenue by expanding its portfolio of prescription drugs, which could lead to further increases in its share prices.

Ekaterina Kiseleva,
Especialista em análise na InstaForex
© 2007-2025
Selecionar intervalo de tempo
5
min
15
min
30
min
1
hora
4
horas
1
dia
1
s.
Ganhe com as variações das taxas das criptomoedas com a InstaForex.
Baixe o MetaTrader 4 e abra a sua primeira operação.
  • Grand Choice
    Contest by
    InstaForex
    InstaForex always strives to help you
    fulfill your biggest dreams.
    PARTICIPE DO CONCURSO

Recommended Stories

US$ 10 bilhões: O preço de um erro – J&J volta aos holofotes

Os indicadores do balanço patrimonial estão em turbulência. As ações das companhias aéreas estão em queda. A J&J também está caindo. Grandes ganhos para nomes recentes de IPO CoreWeave

18:02 2025-04-02 UTC+2

Resumo de notícias do mercado dos EUA para 02 de abril

A Johnson & Johnson enfrentou um sério revés quando um juiz rejeitou um acordo de US$ 10 bilhões sobre reclamações relacionadas ao talco, fazendo com que as ações da empresa

Natalia Andreeva 17:45 2025-04-02 UTC+2

US$ 10 bilhões: O preço dos erros? J&J de volta à tempestade jurídica

Balanços patrimoniais sobrevivem ao dia anterior ao evento das tarifas de Trump Companhias aéreas caem após rebaixamento da Jefferies A J&J cai depois que o juiz rejeita um acordo

Thomas Frank 16:36 2025-04-02 UTC+2

Q1 2025: Mercados registram a maior queda nas taxas desde 2022

S&P e Nasdaq registram o pior mês desde dezembro de 2022 A maior queda trimestral na taxa de juros: S&P desde o terceiro trimestre de 2022, Nasdaq no segundo trimestre

Thomas Frank 18:51 2025-04-01 UTC+2

Resumo de notícias do mercado dos EUA para 1 de abril

Os índices de ações dos EUA fecharam a sessão com resultados mistos: o S&P 500 subiu 0,55%, enquanto o Nasdaq 100 recuou 0,14%. Essa incerteza reflete as preocupações dos investidores

Ekaterina Kiseleva 18:44 2025-04-01 UTC+2

Ouro: O novo rei das crises? Melhor trimestre desde 1986 em meio à turbulência global

Nikkei cai 4%, Nasdaq Futures cai 1,4% Trump diz que as tarifas dos EUA serão aplicadas a todos os países O ouro tem o melhor trimestre desde 1986 Dólar caminha

Thomas Frank 18:24 2025-03-31 UTC+2

Resumo de notícias do mercado dos EUA para 31 de março

O mercado norte-americano iniciou a semana com uma liquidação generalizada, impulsionada pelo aumento das preocupações em torno das tarifas comerciais de retaliação e pela deterioração da confiança do consumidor

Irina Maksimova 15:38 2025-03-31 UTC+2

Ouro brilha na crise: melhor trimestre desde 1986 em meio à turbulência global

O Nikkei recua 4%, e os futuros da Nasdaq caem 1,4%. Trump sinaliza que as tarifas dos EUA abrangerão todos os países. O ouro tem seu melhor trimestre desde 1986

14:38 2025-03-31 UTC+2

Trump pressiona e o mercado de ações reage com uma queda

As ações do setor automotivo caem após o último golpe tarifário de Trump Advanced Micro Devices cai após rebaixamento de corretora Número de pedidos semanais de subsídio de desemprego chega

Thomas Frank 16:44 2025-03-28 UTC+2

Trump mexe os pauzinhos e o mercado de ações afunda em resposta

As ações do setor automotivo caem após a greve tarifária de Trump. A Advanced Micro Devices apresenta queda. Os pedidos de auxílio-desemprego aumentam para 224.000. O dólar se fortalece

15:52 2025-03-28 UTC+2
Não pode falar agora?
Faça sua pergunta no chat.
Widget callback
 

Dear visitor,

Your IP address shows that you are currently located in the USA. If you are a resident of the United States, you are prohibited from using the services of InstaFintech Group including online trading, online transfers, deposit/withdrawal of funds, etc.

If you think you are seeing this message by mistake and your location is not the US, kindly proceed to the website. Otherwise, you must leave the website in order to comply with government restrictions.

Why does your IP address show your location as the USA?

  • - you are using a VPN provided by a hosting company based in the United States;
  • - your IP does not have proper WHOIS records;
  • - an error occurred in the WHOIS geolocation database.

Please confirm whether you are a US resident or not by clicking the relevant button below. If you choose the wrong option, being a US resident, you will not be able to open an account with InstaForex anyway.

We are sorry for any inconvenience caused by this message.